11.07.2015 Views

User Guide to Thresholds and Classification - Environmental ...

User Guide to Thresholds and Classification - Environmental ...

User Guide to Thresholds and Classification - Environmental ...

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

148<strong>User</strong> <strong>Guide</strong> for <strong>Thresholds</strong> <strong>and</strong> <strong>Classification</strong>siv.Acute inhalation <strong>to</strong>xicityA hazard classification may be assigned for acute inhalation <strong>to</strong>xicity for aerosol products. Theclassification assigned should also take in<strong>to</strong> account the propellant in the aerosol.10.3.3. <strong>Classification</strong> of mixtures based on ingredients of the mixture (additivity formula)Data available for all ingredientsThe ATE of ingredients should be considered in the following way.Include ingredients (including impurities <strong>and</strong> additives) with a known acute <strong>to</strong>xicity, that fall in<strong>to</strong> any ofthe HSNO Act acute <strong>to</strong>xicity categories.Ignore ingredients that are presumed not acutely <strong>to</strong>xic (for example, water <strong>and</strong> sugar).Ignore ingredients if the oral limit test does not show acute <strong>to</strong>xicity at 2,000 mg/kg bw.Ingredients that fall within the scope of this paragraph are considered <strong>to</strong> be ingredients with a known ATE.The ATE of the mixture is determined using the ATE values for all relevant ingredients, according <strong>to</strong> thefollowing formula for oral, dermal, or inhalation <strong>to</strong>xicity:C a /ATE a + C b /ATE b + ...+ C z /ATE z = 100/ATE mixWhere:C a = percentage of the component in the substance as a mixtureATE a = acute <strong>to</strong>xicity estimate of componentATE mix = estimated LD 50 of the mixtureSee the worked examples in Appendix 10B.Data are not available for one or more ingredients of the mixtureWhen an ATE is not available for an individual ingredient of the mixture, but information such as that listedbelow can provide a derived conversion value (see Table 10.2) the formula above may be applied.This may include evaluating:the extrapolation between oral, dermal, <strong>and</strong> inhalation ATEs, 2 which could require appropriatepharmacodynamic <strong>and</strong> pharmacokinetic data;evidence from human exposure that indicates <strong>to</strong>xic effects but does not provide lethal dose data;evidence from any other <strong>to</strong>xicity tests <strong>and</strong> assays available on the substance that indicates <strong>to</strong>xic acuteeffects but does not necessarily provide lethal dose data; ordata from closely analogous substances using structure activity relationships.This approach generally requires substantial supplemental technical information <strong>and</strong> a highly trained <strong>and</strong>experienced expert <strong>to</strong> reliably estimate acute <strong>to</strong>xicity. If such information is not available, follow theprovisions below.2For ingredients with ATEs available for other than the most appropriate exposure route, values may be extrapolatedfrom the available exposure route <strong>to</strong> the most relevant route.January 2012 EPA0109

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!